Here are four things to know:
1. PRP treatment involves a concentration of platelets and growth factors from the patient’s blood, stem cells or bone marrow.
2. The technique aims to nourish the remaining cartilage and stimulate the patient’s cells to prevent them from sending destructive enzymes into the joint, CNOS orthopedic surgeon Raymond Sherman, MD, told KTIV News.
3. Dr. Sherman said the effect of the PRP injections lasts longer than cortisone injections, which are used to provide short-term pain relief for arthritis and joint pain.
4. CNOS first began using PRP injections two years ago, according to the report.
More articles on biologics:
DiscGenics gets green light for clinical trial in Japan: 5 details
Kuros Biosciences receives FDA clearance to extend MagnetOs Putty applications: 3 insights
Kuros Biosciences’ MagnetOs equivalent to autograft in spinal fusion, study finds: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
